| Basics |
iRhythm Technologies, Inc.
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities.
|
| IPO Date: |
October 20, 2016 |
| Sector: |
Healthcare |
| Industry: |
Medical Instruments and Equipment |
| Market Cap: |
$4.28B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$2.29 | 2.27%
|
| Avg Daily Range (30 D): |
$1.85 | 1.29%
|
| Avg Daily Range (90 D): |
$1.77 | 1.44%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.35M |
| Avg Daily Volume (30 D): |
.3M |
| Avg Daily Volume (90 D): |
.36M |
| Trade Size |
| Avg Trade Size (Sh.): |
54 |
| Avg Trade Size (Sh.) (30 D): |
31 |
| Avg Trade Size (Sh.) (90 D): |
36 |
| Institutional Trades |
| Total Inst.Trades: |
4,313 |
| Avg Inst. Trade: |
$2.94M |
| Avg Inst. Trade (30 D): |
$7.61M |
| Avg Inst. Trade (90 D): |
$5.54M |
| Avg Inst. Trade Volume: |
.03M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.77M |
| Avg Closing Trade (30 D): |
$9.94M |
| Avg Closing Trade (90 D): |
$7.45M |
| Avg Closing Volume: |
36.4K |
|
|
| Financials |
| |
TTM |
Q4 2024 |
FY 2024 |
|
Basic EPS
|
$-.97
|
$-.04
|
$-3.63
|
|
Diluted EPS
|
$-.97
|
$-.04
|
$-3.63
|
|
Revenue
|
$ 158.68M
|
$ 164.33M
|
$ 591.84M
|
|
Gross Profit
|
$ 109.22M
|
$ 115.07M
|
$ 407.53M
|
|
Net Income / Loss
|
$ -30.7M
|
$ -1.33M
|
$ -113.29M
|
|
Operating Income / Loss
|
$ -32.56M
|
$ -4.08M
|
$ -115.51M
|
|
Cost of Revenue
|
$ 49.46M
|
$ 49.26M
|
$ 184.31M
|
|
Net Cash Flow
|
$ -44.3M
|
$ -99.94M
|
$ 391.79M
|
|
PE Ratio
|
|
|
|
|
|
|
